HPV-targeted cancer therapy faces a setback as BioNTech's BNT113 misses its first major clinical trial endpoint in head and neck cancer.
Zydus' Keytruda biosimilar FYB206 enters FDA review without a comparative Phase III efficacy trial, highlighting a shift in biosimilar development.
ALK7 RNAi therapy is emerging as a potential alternative approach to obesity treatment as Roche expands its experimental drug pipeline.
Karnataka introduces transparent medicine pricing details on hospital bills from November 1, helping patients compare procurement costs, MRP and final charges.
ReadyFlow works equally well in the arm or thigh, with new data supporting consistent drug exposure and diuretic effects.
Lung health research advances on two fronts as scientists link microbiome changes to lingering Covid symptoms, while IPF drug trials deliver contrasting results.
Arthritis care starts with informed daily choices. This World Arthritis Day, experts highlight essential do’s and don’ts to protect joint health, manage symptoms, and maintain mobility.
AI drug discovery funding in India gains momentum as TDB backs Peptris with Rs 86 crore to advance four drug candidates through preclinical development.
Drug testing laboratories in India face capacity constraints as regulators retain existing testing timelines and promote stronger infrastructure and digital oversight.
Emcure Pharmaceuticals moves to simplify its corporate structure as its board approves a draft merger scheme to absorb subsidiaries Emcutix Biopharmaceuticals and Zuventus Healthcare.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
